The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies
Adenosine (Ado) is significantly elevated in the tumor microenvironment (TME) compared to normal tissues. It binds to adenosine receptors (AdoRs), suppressing tumor antigen presentation and immune cell activation, thereby inhibiting tumor adaptive immunity. Ado downregulates major histocompatibility...
Saved in:
Main Authors: | Longsheng Wang (Author), Jie Zhang (Author), Wenxin Zhang (Author), Mingming Zheng (Author), Hongjie Guo (Author), Xiaohui Pan (Author), Wen Li (Author), Bo Yang (Author), Ling Ding (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies
by: Tiecheng Zhong, et al.
Published: (2022) -
The impact of lipids on the cancer-immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy
by: Mingming Zheng, et al.
Published: (2023) -
Author correction to 'Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA' [Acta Pharmaceutica Sinica B 13 (2023) 2585-2600]
by: Wenxin Zhang, et al.
Published: (2023) -
Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
by: Wenxin Zhang, et al.
Published: (2023) -
Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses
by: Xi Chen, et al.
Published: (2020)